Timely Prostate Cancer Prognosis Of Low Grade Instances Can Help You Live Longer

The best way to ensure that you succeed in living a long and healthy life is to remain free from diseases; this can ensure that you are able to add as many as ten to fifteen years to your lifespan and requires, in the case of any health related problems, having prognosis of the condition done well in time. In the case of prostate cancer prognosis, it will help if your tumor is slow in developing and is also of the small size. Fortunately, there is enough evidence to show that as many as, it is believed, three-fourths of all those who have recently been diagnosed with prostate cancer and who have localized tumors will survive and live on for many more years.

Different Stages

There are different stages of prostate cancer and so, any prostate cancer prognosis done must deal with these different types. Typically, prostate cancer prognosis for Stage I and Stage II prostate cancer is the more common one and chances of survival in such cases are on the high side. In case you fall in the bracket of patients in the median age of seventy-two years you can expect to live no longer than another ten to fourteen years. However, if your prostate cancer is of a low grade you can expect to live even longer.

Once the prostate cancer prognosis has been performed, you can then adopt different actions in order to combat the disease. Watchful waiting is one option open to you; surgery or even radiation therapy is another option and is ideally suited for men whose tumors are poorly differentiated.

Prostate cancer trails only lung cancer as being the most deadly form of cancer and it is especially most dangerous for American males. However, since most prostate tumors are of low grade and do not grow rapidly, chances of survival will improve when prostate cancer prognosis is able to establish the presence of the disease at an early stage. In fact, it is believed that rates of curing prostate cancer when the disease is prognosis is done at an early stage are as high as an astonishing ninety-eight percent.

In case prostate cancer prognosis is done when the disease is at a later stage and when the disease has spread beyond your prostate gland you will experience greater difficulties in finding a suitable cure; nevertheless, rate of survival can be improved upon except when metastasized cancer has developed.

It is certainly worthwhile understanding what steps to take in regard to prostate cancer prevention and in this regard the scientific as well as medical community has spared no effort in coming up with suitable solutions.

Prostate cancer prognosis can also involve cases in which the disease recurs; even so, the good news is that such problems are curable – provided that the disease is contained inside of the prostate and not allowed to spread.


Radically Improve Your Prostate Health - Click Here

 

Prostate News:


Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict ... - CNNMoney.com (press release)
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict ...CNNMoney.com (press release)PROLARIS is a molecular diagnostic assay that offers urologists a more accurate way of determining a prostate cancer patient's risk of recurrence. ...and more »..

Screening for prostate cancer? Patients should decide (CNN)
This week, the American Cancer Society releases updated prostate cancer screening guidelines. The guidelines say "men should discuss the uncertainties, risks and possible benefits of screening for prostate cancer before deciding whether to be tested."..

Generic Drug for Enlarged Prostate Approved - WebMD
TopNews United StatesGeneric Drug for Enlarged Prostate ApprovedWebMDBPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer. The most common side effects with UROXATRAL ...FDA Okays Generic of BPH DrugMedPage Todayall 154 news articles »..

A new, $3400 test for prostate cancer recurrence « THE "NEW ...
Myriad Genetics has announced the launch of a 46-gene prognostic test which is supposed to be able to determine the risk of prostate cancer recurrence in patients who have undergone a radical prostatectomy. .....

Pants Off for Prostate Cancer Toronto's Newest and Most Innovative Fundraising ... - SYS-CON Media (press release)
Pants Off for Prostate Cancer Toronto's Newest and Most Innovative Fundraising ...SYS-CON Media (press release)Prostate cancer is the most common cancer among Canadian men, affecting 1 in 6 Canadian men in their lifetime. In the coming year alone, over 25000 Canadian ...Gold underpants spotted on London landmarksIndependentall 7 news articles »..

New American Cancer Society guidance urges docs to explain limits of prostate cancer screening (Minneapolis-St. Paul Star Tribune)
ATLANTA - The American Cancer Society is urging doctors to make clearer to men that the test used to screen for prostate cancer has limits and may lead to unnecessary treatments that do more harm than good...

We Need Your Help Now :: Advanced Prostate Cancer
This program is the only federally funded research initiative specifically dedicated to prostate cancer. Historically, this program supports cutting edge research which has already had great impact on our current knowledge of prostate .....

Abiraterone Produces Promising Results in Men with Hormone ...
According to the results of Phase II clinical trials, the investigational drug abiraterone appears to be active in men with hormone refractory prostate cancer (HRPC). These results were published in the Journal of Clinical Oncology...

Olivia Newton-John to Host Pink and Blue for Two Cancer Fundraiser - Look To The Stars
Olivia Newton-John to Host Pink and Blue for Two Cancer FundraiserLook To The StarsJoining her will be author Dr. Ernie Bodai, survivor of prostate cancer, and the man behind the Breast Cancer Research Stamp – the first ever stamp in US ...and more »..

“Prostate Cancer: New Questions About Screening and Treatment ...
To: The House Committee on Oversight and Government Reform Re: “Prostate Cancer: New Questions About Screening and Treatment” March 4, 2010 We...

Let men decide on prostate screening, cancer society says (CNN)
Most men 50 and older should seriously consider the potential risks of treatment before deciding whether to be screened for prostate cancer, the American Cancer Society said Wednesday in revised guidelines...

Much Needed Hearing in House Oversight Committee to Address ...
Women Against Prostate Cancer (WAPC) is a national cancer support organization working to unite voices and provide a support group women affected by p...

No new FDA advisory committee meeting for Provenge « THE "NEW ...
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families. This web site is a service of Prostate Cancer .....

Education should accompany prostate screening, new guidelines say - Los Angeles Times
ABC NewsEducation should accompany prostate screening, new guidelines sayLos Angeles TimesNew guidelines for prostate cancer screening issued Wednesday emphasize that physicians should better educate men about both the risks ...Cancer Society Casts Doubt on Value of Prostate Cancer TestFOXNewsLet men decide on prostate screening, cancer society saysCNNNew guidelines on prostate cancer urge frank talkReutersU.S. News & World Report -Medscape -BusinessWeekall 585 news articles »..

Dendreon: Updated Data Show Prostate-Cancer Drug Extends Life - Wall Street Journal
BNETDendreon: Updated Data Show Prostate-Cancer Drug Extends LifeWall Street Journal(DNDN) said updated results for a Phase III study of its prostate-cancer drug showed it extended overall survival of men with metastatic castrate-resistant ...Dendreon: Provenge boosts survival 40 pctReutersUpdated Data On Dendreon's (DNDN) Prostate Cancer Drug PROVENGE Shows ...StreetInsider.com (subscription)Dendreon Follow-Up Confirms Survival Edge, Helping Fend off Sanofi RivalXconomyBusinessWeek -BNET -Forbes (blog)all 64 news articles »..

Sanofi drug boosts prostate cancer survival 30 pct - Reuters
NOLA.comSanofi drug boosts prostate cancer survival 30 pctReutersPA) experimental chemotherapy drug Jevtana increases survival by 30 percent in men with prostate cancer whose tumours no longer respond to standard ...Positive Test for Sanofi Prostate Cancer DrugNew York TimesSanofi drug shows promise against prostate cancerThe Associated PressNew prostate-cancer drug could help thousands, Tulane-led study showsNOLA.comWWL -CNBC -MedPage Todayall 133 news articles »..

Seven things you didn't know about St. Jude - ESPN (blog)
ESPN (blog)Seven things you didn't know about St. JudeESPN (blog)A year ago, Karl spoke about his dedication to St. Jude, and his previous battle with prostate cancer. Then he discussed the day he learned his son Coby ...St. Jude Hospital has special meaning for Grizzlies' GayNBA.comall 5 news articles »..

US prostate cancer patients — write your Congress(wo)man NOW ...
In the U.S. House of Representatives, Jim Marshall (GA) and Peter King (NY) are currently circulating a letter to colleagues asking for their support for increased funding for the Prostate Cancer Research Program (PCRP) — part of the .....

New Drugs, Approaches Offer Hope Against Prostate Cancer - Palm Beach Post
New Drugs, Approaches Offer Hope Against Prostate CancerPalm Beach PostScientists are making headway in finding ways to treat and detect stubborn forms of prostate cancer. The new hope comes from three studies being presented ...and more »..

Radically Improve Your Prostate Health - Click Here

Technorati Tags: , ,

Google